President Phuc witnesses signing of numerous Vietnam-Cuba cooperation programs

As a leading biotechnology centre of Cuba, the CIGB has successfully researched and produced five types of vaccines against COVID-19, including Abdala, making Cuba the first and only Latin American-Caribbean nation to research and produce its own COVID-19 vaccines.

The Center produces many pharmaceutical products such as vaccines, cancer drugs, and diagnostic technologies.

At the CIGB, President Phuc witnessed the signing of an agreement between the CIGB and the Centre for Research and Production of Vaccines and Biologicals (POLYVAC) under the Vietnamese Ministry of Health on purchasing 5 million doses of COVID-19 vaccines from Cuba. Businesses of both sides also signed deals on the transfer of Soberana 2 COVID-19 vaccine.

Upon addressing after the signing ceremony, President Nguyen Xuan Phuc said he is elated to witness this important event which is a very important success of his trip.

CIGB leaders showed their elation to see many Vietnamese partners desire to cooperate with the Center in both distribution and technology transfer for the production of pharmaceuticals, vaccines, including the Abdala vaccine.

According to Deputy Minister of Health Tran Van Thuan, during the President's visit, both nations’ health ministries have reached a series of agreements on eight cooperation contents in research, training, technology transfer and production of medicines.

He expressed his hope that health care partnership between the two countries will continue to grow and flourish on a par with the sound relations between the two nations.

Following his visit to the Centre, PM Phuc visited General Raul Castro Ruz before departing Havana for Santiago, the second largest city of the Caribbean nation.

After concluding the Cuban visit, he is set to jet off to New York for a general debate of the UN General Assembly’s 76th session and an array of bilateral activities in the US.